CSASF(CSASF)
CSASF
No analyst ratings available
No analyst price targets available for CSASF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $517.73B | $550.19B | $587.79B | $621.42B | $656.29B |
| Low | $498.49B | $522.03B | $561.69B | $593.83B | $627.15B |
| High | $540.24B | $605.44B | $630.62B | $666.70B | $704.11B |
| EBITDA Avg | $32.70B | $30.92B | $29.84B | $29.25B | $29.10B |
| Low | $32.66B | $30.88B | $29.79B | $29.20B | $29.05B |
| High | $32.77B | $30.99B | $29.92B | $29.33B | $29.19B |
| EBIT Avg | $707M | $756M | $829M | $873M | $951M |
| Low | $666M | $712M | $781M | $822M | $896M |
| High | $774M | $828M | $907M | $955M | $1.04B |
| Net Income Avg | $505M | $540M | $592M | $623M | $679M |
| Low | $476M | $508M | $558M | $587M | $639M |
| High | $552M | $591M | $648M | $682M | $743M |
| EPS Avg | $551.83 | $590.09 | $647.05 | $681.31 | $742.05 |
| Low | $519.98 | $556.04 | $609.71 | $641.99 | $699.23 |
| High | $604.10 | $645.99 | $708.34 | $745.85 | $812.35 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $128.71B | $134.72B | $133.12B | $136.61B |
| Low | $128.30B | $132.03B | $131.54B | $134.99B |
| High | $129.12B | $137.42B | $134.69B | $138.23B |
| EBITDA Avg | $8.26B | $8.14B | $8.01B | $7.94B |
| Low | $8.25B | $8.14B | $8.00B | $7.93B |
| High | $8.26B | $8.15B | $8.01B | $7.94B |
| EBIT Avg | $170M | $181M | $168M | $204M |
| Low | $167M | $178M | $165M | $201M |
| High | $173M | $184M | $170M | $207M |
| Net Income Avg | $121M | $129M | $120M | $145M |
| Low | $119M | $127M | $118M | $143M |
| High | $123M | $131M | $122M | $148M |
| EPS Avg | $137.36 | $146.35 | $135.59 | $164.63 |
| Low | $135.25 | $144.10 | $133.50 | $162.10 |
| High | $139.47 | $148.60 | $137.67 | $167.16 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |